Skip to main menu Skip to main content Skip to footer
neurotech logo
  • Accessibility Menu
  • About Us
    • Our Team
    • Careers
    • Contact Us
  • Our Newly Approved Product
  • Science & Technology
    • Publications
  • Clinical
  • Patients
  • News

Category: Featured

Home » Featured » Page 2

Media Contact

Laurie Ferguson
l.ferguson@neurotechusa.com

Click to read Neurotech Pharmaceuticals Appoints Thomas Aaberg Jr., M.D. as Chief Medical Officer

October 31, 2021

Neurotech Pharmaceuticals Appoints Thomas Aaberg Jr., M.D. as Chief Medical Officer

 Click to read Fast Track Designation Granted for Macular Telangiectasia Type 2 (MacTel)

December 17, 2018

Fast Track Designation Granted for Macular Telangiectasia Type 2 (MacTel)

 Click to read Neurotech Announces Positive Phase 2 Results in NT-501 (CNTF) for Macular Telangiectasia.

June 17, 2017

Neurotech Announces Positive Phase 2 Results in NT-501 (CNTF) for Macular Telangiectasia.

 Click to read Neurotech Announces Renewed Focus on NT-501 (CNTF) Encapsulated Cell Therapy Clinical Programs.

April 29, 2016

Neurotech Announces Renewed Focus on NT-501 (CNTF) Encapsulated Cell Therapy Clinical Programs.

 Click to read Two-Year Intraocular Delivery of Ciliary Neurotrophic Factor by Encapsulated Cell Technology Implant

November 2, 2013

Two-Year Intraocular Delivery of Ciliary Neurotrophic Factor by Encapsulated Cell Technology Implant

Two-Year Intraocular Delivery of Ciliary Neurotrophic Factor by Encapsulated Cell Technology Implants in Patients with Chronic Retinal Degenerative Diseases by Kauper et al.

 Click to read James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals.

August 6, 2013

James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals.

 Click to read NT-501 Granted Orphan-Drug Designation for Macular Telangiectasia Type 2 (MacTel)

July 24, 2012

NT-501 Granted Orphan-Drug Designation for Macular Telangiectasia Type 2 (MacTel)

< 1 2
neurotech logo
About Us Science & Technology Clinical Patients News Careers Publications Contact Us Supplier Code of Conduct Policy Accessibility Statement Privacy Policy Terms and Conditions of Use Policy
Stay Connected with our
Linked
,
Twitter
,
and
Instagram
,
accounts
Main Phone Number
Phone Icon 401-333-3880
Headquarters
Map Pin Icon
900 Highland Corporate Drive, Suite 101
Cumberland, RI 02864
Commercial Office
Map Pin Icon
75 Second Ave, Suite 700
Needham, MA 02494
© Neurotech Pharmaceuticals, Inc. 2025
Designed by Glacial Multimedia.
⇧